Activation	O
of	O
the	O
transcription	B-protein
factor	I-protein
MEF2C	B-protein
by	O
the	O
MAP	B-protein
kinase	I-protein
p38	I-protein
in	O
inflammation	O
.	O

For	O
cells	O
of	O
the	O
innate	O
immune	O
system	O
to	O
mount	O
a	O
host	O
defence	O
response	O
to	O
infection	O
,	O
they	O
must	O
recognize	O
products	O
of	O
microbial	O
pathogens	O
such	O
as	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
the	O
endotoxin	O
secreted	O
by	O
Gram-negative	O
bacteria	O
.	O

These	O
cellular	O
responses	O
require	O
intracellular	O
signalling	O
pathways	O
,	O
such	O
as	O
the	O
four	O
MAP	B-protein
kinase	I-protein
(	O
MAPK	B-protein
)	O
pathways	O
.	O

In	O
mammalian	O
cells	O
the	O
MAPK	B-protein
p38	I-protein
is	O
thought	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
cellular	O
responses	O
during	O
infection	O
through	O
its	O
effects	O
on	O
the	O
expression	O
of	O
proinflammatory	B-protein
molecules	I-protein
.	O

One	O
means	O
of	O
understanding	O
the	O
role	O
of	O
p38	B-protein
in	O
these	O
responses	O
is	O
to	O
identify	O
proteins	O
with	O
functions	O
regulated	O
by	O
p38	B-protein
-catalysed	O
phosphorylation	O
.	O

Here	O
we	O
demonstrate	O
a	O
link	O
between	O
the	O
p38	B-protein
pathway	O
and	O
a	O
member	O
of	O
the	O
myocyte-enhancer	B-protein
factor	I-protein
2	I-protein
(	I-protein
MEF2	I-protein
)	I-protein
group	I-protein
of	O
transcription	B-protein
factors	I-protein
.	O

We	O
found	O
that	O
in	O
monocytic	B-cell_type
cells	I-cell_type
,	O
LPS	O
increases	O
the	O
transactivation	O
activity	O
of	O
MEF2C	B-protein
through	O
p38	B-protein
-catalysed	O
phosphorylation	O
.	O

One	O
consequence	O
of	O
MEF2C	B-protein
activation	O
is	O
increased	O
c-jun	B-DNA
gene	I-DNA
transcription	O
.	O

Our	O
results	O
show	O
that	O
p38	B-protein
may	O
influence	O
host	O
defence	O
and	O
inflammation	O
by	O
maintaining	O
the	O
balance	O
of	O
c-Jun	B-protein
protein	I-protein
consumed	O
during	O
infection	O
.	O

letters	NULL
to	NULL
nature	NULL
15	NULL
.	NULL

Zhang	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Reddick	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Burkey	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Maeda	NULL
,	NULL
N.	NULL
Diet-induced	NULL
atherosclerosis	NULL
in	NULL
mice	NULL
heterozygous	NULL
and	NULL
homozygous	NULL
for	NULL
apolipoprotein	NULL
E	NULL
gene	NULL
disruption	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

94	NULL
,	NULL
937-945	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

16	NULL
.	NULL

Plump	NULL
,	NULL
A.	NULL
S.	NULL
et	NULL
al	NULL
.	NULL

Severe	NULL
hypercholesterolemia	NULL
and	NULL
atherosclerosis	NULL
in	NULL
apolipoprotein	NULL
E-deficient	NULL
mice	NULL
created	NULL
by	NULL
homolagous	NULL
recombination	NULL
in	NULL
ES	NULL
cells	NULL
.	NULL

Cell	NULL
71	NULL
,	NULL
343-353	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

7	NULL
.	NULL

Holness	NULL
,	NULL
C	NULL
,	NULL
L.	NULL
,	NULL
da	NULL
Silva	NULL
,	NULL
R.	NULL
R	NULL
,	NULL
Fawcett	NULL
,	NULL
J.	NULL
,	NULL
macrophage-restricted	NULL
glycoprotein	NULL
,	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
lamp/lgp	NULL
family	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
,	NULL
268	NULL
,	NULL
9661-9666	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

18	NULL
.	NULL

Elomaa	NULL
,	NULL
O.	NULL
er	NULL
al	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
novel	NULL
bacteria-binding	NULL
receptor	NULL
structurally	NULL
related	NULL
to	NULL
scavenger	NULL
receptors	NULL
and	NULL
expressed	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
macrophages	NULL
.	NULL

Cell	NULL
80	NULL
,	NULL
603-609	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Ramprasad	NULL
,	NULL
M.	NULL
P.	NULL
et	NULL
al	NULL
.	NULL

The	NULL
94-	NULL
to	NULL
97-kDa	NULL
mouse	NULL
macrophage	NULL
membrane	NULL
protein	NULL
that	NULL
recognizes	NULL
oxidized	NULL
low	NULL
density	NULL
lipoprotein	NULL
and	NULL
phosphatidylserine-rich	NULL
liposomes	NULL
is	NULL
identical	NULL
to	NULL
macrosialin	NULL
,	NULL
the	NULL
mouse	NULL
homologue	NULL
of	NULL
human	NULL
â‚¬D68	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
,	NULL
9580-9584	NULL
(	NULL
1995	NULL
)	NULL
,	NULL
20	NULL
.	NULL

Endemann	NULL
,	NULL
G.	NULL
er	NULL
al	NULL
.	NULL

CD36	NULL
is	NULL
a	NULL
receptor	NULL
for	NULL
oxidized	NULL
low	NULL
density	NULL
lipoprotein	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
11811-11816	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

21	NULL
.	NULL

Acton	NULL
,	NULL
S.	NULL
et	NULL
al	NULL
.	NULL

Identification	NULL
of	NULL
scavenger	NULL
receptor	NULL
SR-B1	NULL
as	NULL
a	NULL
high	NULL
density	NULL
lipoporotein	NULL
receptor	NULL
.	NULL

Science	NULL
271	NULL
,	NULL
518-520	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

.	NULL

22	NULL
.	NULL

Azuma	NULL
,	NULL
S.	NULL
&	NULL
Toyoda	NULL
,	NULL
Y	NULL
.	NULL

Production	NULL
of	NULL
a	NULL
germ-line	NULL
chimeric	NULL
mouse	NULL
derived	NULL
from	NULL
newly	NULL
established	NULL
embryonic	NULL
stem	NULL
cells	NULL
.	NULL

Jpn	NULL
.	NULL

/	NULL
.	NULL

Anim	NULL
.	NULL

Reprod	NULL
.	NULL

37	NULL
,	NULL
37-43	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

23	NULL
.	NULL

Kurihara	NULL
,	NULL
Y.	NULL
et	NULL
al	NULL
.	NULL

Elevated	NULL
blood	NULL
pressure	NULL
and	NULL
craniofacial	NULL
abnormalities	NULL
in	NULL
mice	NULL
deficient	NULL
in	NULL
endothelin-1	NULL
.	NULL

Nature	NULL
368	NULL
,	NULL
703-710	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

24	NULL
.	NULL

Suzuki	NULL
,	NULL
H.	NULL
,	NULL
Togashi	NULL
,	NULL
M.	NULL
,	NULL
Moriguchi	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Adachi	NULL
,	NULL
J	NULL
.	NULL

Relationship	NULL
between	NULL
age-related	NULL
decline	NULL
in	NULL
fertility	NULL
and	NULL
in	NULL
vifre	NULL
fertilization	NULL
rate	NULL
in	NULL
IVCS	NULL
mice	NULL
.	NULL

/	NULL
.	NULL

Reprod	NULL
.	NULL

Dev	NULL
.	NULL

40	NULL
,	NULL
107-116	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

25	NULL
.	NULL

Cynshi	NULL
,	NULL
O.	NULL
et	NULL
al	NULL
.	NULL

Characterization	NULL
of	NULL
aggregated	NULL
low	NULL
density	NULL
lipoproteins	NULL
induced	NULL
by	NULL
copper-	NULL
catalyzed	NULL
oxidation	NULL
.	NULL

J.	NULL
Atheroscler	NULL
.	NULL

Thromb	NULL
.	NULL

1	NULL
,	NULL
87-97	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

26	NULL
.	NULL

Takata	NULL
,	NULL
K.	NULL
et	NULL
al	NULL
.	NULL

Endocytic	NULL
uptake	NULL
of	NULL
nonenzymatically	NULL
glycosylated	NULL
proteins	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
scavenger	NULL
receptor	NULL
for	NULL
aldehyde-modified	NULL
proteins	NULL
.	NULL

J	NULL
,	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263	NULL
,	NULL
14819-14825	NULL
(	NULL
1988	NULL
)	NULL
.	NULL

27	NULL
.	NULL

Irie	NULL
,	NULL
H.	NULL
et	NULL
al	NULL
.	NULL

Spread	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
type-1	NULL
(	NULL
Miyama	NULL
-GC	NULL
strain	NULL
}	NULL
to	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
after	NULL
intraperitoneal	NULL
inoculation	NULL
:	NULL
the	NULL
role	NULL
of	NULL
the	NULL
myenteric	NULL
plexus	NULL
of	NULL
the	NULL
gut	NULL
.	NULL

Arch	NULL
.	NULL

Virol	NULL
.	NULL

105	NULL
,	NULL
247-257	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

28.	NULL
van	NULL
Berkel	NULL
,	NULL
T.	NULL
J.	NULL
C.	NULL
,	NULL
Kruijt	NULL
,	NULL
J.	NULL
K.	NULL
&	NULL
Kempen	NULL
,	NULL
H.-J	NULL
.	NULL

M.	NULL
Specific	NULL
targeting	NULL
of	NULL
high	NULL
density	NULL
lipoproteins	NULL
to	NULL
liver	NULL
hepatocytes	NULL
by	NULL
incorporation	NULL
of	NULL
a	NULL
tris-galactoside-terminated	NULL
cholesterol	NULL
derivative	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
,	NULL
260	NULL
,	NULL
12203-12207	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

Gordon	NULL
,	NULL
$	NULL
.	NULL

&	NULL
Simmons	NULL
,	NULL
D.	NULL
Macrosialin	NULL
,	NULL
a	NULL
mouse	NULL
ha	NULL
Acknowledgements	NULL
.	NULL

We	NULL
thank	NULL
M.	NULL
Matsumoto	NULL
for	NULL
bacteria	NULL
;	NULL
M.	NULL
Krieger	NULL
,	NULL
M.	NULL
Freeman	NULL
and	NULL
D.	NULL
Steinberg	NULL
for	NULL
encouragement	NULL
;	NULL
S.	NULL
Uchida	NULL
,	NULL
M.	NULL
Miwa	NULL
,	NULL
Y.	NULL
Imai	NULL
and	NULL
T.	NULL
Iwasawa	NULL
for	NULL
technical	NULL
assistance	NULL
;	NULL
and	NULL
P.	NULL
Kowalski-Saunders	NULL
and	NULL
K.	NULL
Boru	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
Correspondence	NULL
and	NULL
requests	NULL
for	NULL
materials	NULL
should	NULL
be	NULL
addressed	NULL
to	NULL
TK	NULL
.	NULL

{	NULL
e-mail	NULL
:	NULL
kodama	NULL
@	NULL
bme.rcast	NULL
.	NULL

u-takyc.ac.jp	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
MEF2C	NULL
by	NULL
the	NULL
MAP	NULL
kinase	NULL
p38	NULL
in	NULL
inflammation	NULL
J.	NULL
Han	NULL
,	NULL
Y.	NULL
Jiang	NULL
,	NULL
Z.	NULL
Li	NULL
,	NULL
V.	NULL
V.	NULL
Kravchenko	NULL
&	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
The	NULL
Scripps	NULL
Research	NULL
Institute	NULL
,	NULL
10550	NULL
North	NULL
Torrey	NULL
Pines	NULL
Road	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
California	NULL
92037	NULL
,	NULL
USA	NULL
For	NULL
cells	NULL
of	NULL
the	NULL
innate	NULL
immune	NULL
system	NULL
to	NULL
mount	NULL
a	NULL
host	NULL
defence	NULL
response	NULL
to	NULL
infection	NULL
,	NULL
they	NULL
must	NULL
recognize	NULL
products	NULL
of	NULL
microbial	NULL
pathogens	NULL
such	NULL
as	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
the	NULL
endotoxin	NULL
secreted	NULL
by	NULL
Gram-negative	NULL
bacteria	NULL
'	NULL
.	NULL

These	NULL
cellular	NULL
responses	NULL
require	NULL
intracellular	NULL
signalling	NULL
pathways	NULL
,	NULL
such	NULL
as	NULL
the	NULL
four	NULL
MAP	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
pathways	NULL
``	NULL
.	NULL

In	NULL
mammalian	NULL
cells	NULL
the	NULL
MAPK	NULL
p38	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cellular	NULL
responses	NULL
during	NULL
infection	NULL
through	NULL
its	NULL
effects	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
proinflammatory	NULL
molecules	NULL
'	NULL
.	NULL

One	NULL
means	NULL
of	NULL
understanding	NULL
the	NULL
role	NULL
of	NULL
p38	NULL
in	NULL
these	NULL
responses	NULL
is	NULL
to	NULL
identify	NULL
proteins	NULL
with	NULL
functions	NULL
regulated	NULL
by	NULL
p38-catalysed	NULL
phosphorylation	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
a	NULL
link	NULL
between	NULL
the	NULL
p38	NULL
pathway	NULL
and	NULL
a	NULL
member	NULL
of	NULL
the	NULL
myocyte-enhancer	NULL
factor	NULL
2	NULL
(	NULL
MEF2	NULL
)	NULL
group	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

We	NULL
found	NULL
that	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
LPS	NULL
increases	NULL
the	NULL
transactivation	NULL
activity	NULL
of	NULL
MEF2C	NULL
``	NULL
``	NULL
~	NULL
``	NULL
through	NULL
p38-catalysed	NULL
phosphorylation	NULL
.	NULL

One	NULL
consequence	NULL
of	NULL
MEF2C	NULL
activation	NULL
is	NULL
increased	NULL
c-jun	NULL
gene	NULL
transcription	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
p38	NULL
may	NULL
influence	NULL
host	NULL
defence	NULL
and	NULL
inflammation	NULL
by	NULL
maintaining	NULL
the	NULL
balance	NULL
of	NULL
c-Jun	NULL
protein	NULL
consumed	NULL
during	NULL
infection	NULL
.	NULL

We	NULL
used	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
to	NULL
identify	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
p38	NULL
.	NULL

Because	NULL
active	NULL
kinase-substrate	NULL
interactions	NULL
may	NULL
be	NULL
transient	NULL
,	NULL
we	NULL
used	NULL
a	NULL
kinase-inactive	NULL
mutant	NULL
of	NULL
p38	NULL
to	NULL
favour	NULL
the	NULL
formation	NULL
of	NULL
stable	NULL
protein-protein	NULL
complexes	NULL
``	NULL
.	NULL

We	NULL
used	NULL
as	NULL
targets	NULL
two	NULL
constructs	NULL
of	NULL
p38	NULL
that	NULL
were	NULL
produced	NULL
by	NULL
fusing	NULL
the	NULL
cDNA	NULL
of	NULL
the	NULL
p38	NULL
coding	NULL
region	NULL
(	NULL
wtp38	NULL
)	NULL
or	NULL
a	NULL
p38	NULL
mutant	NULL
with	NULL
the	NULL
TGY	NULL
dual	NULL
phosphorylation	NULL
site	NULL
mutated	NULL
to	NULL
AGF	NULL
(	NULL
TY	NULL
mutant	NULL
)	NULL
to	NULL
the	NULL
carboxy	NULL
296	NULL
terminus	NULL
of	NULL
the	NULL
GAL4	NULL
DNA-binding	NULL
domain	NULL
in	NULL
the	NULL
pAS1	NULL
vector	NULL
``	NULL
.	NULL

A	NULL
human	NULL
fetal	NULL
brain	NULL
cDNA	NULL
library	NULL
fused	NULL
with	NULL
the	NULL
GAL4	NULL
activation	NULL
domain	NULL
placed	NULL
in	NULL
the	NULL
pGAD1IO	NULL
was	NULL
screened	NULL
using	NULL
the	NULL
two	NULL
p38	NULL
constructs	NULL
.	NULL

By	NULL
screening	NULL
10	NULL
``	NULL
transformants	NULL
we	NULL
identified	NULL
five	NULL
positive	NULL
clones	NULL
which	NULL
interacted	NULL
with	NULL
the	NULL
TY	NULL
mutant	NULL
;	NULL
in	NULL
contrast	NULL
,	NULL
no	NULL
clones	NULL
were	NULL
obtained	NULL
when	NULL
wtp38	NULL
was	NULL
used	NULL
in	NULL
the	NULL
screen	NULL
.	NULL

To	NULL
address	NULL
the	NULL
specificity	NULL
of	NULL
these	NULL
interactions	NULL
a	NULL
mating	NULL
experiment	NULL
was	NULL
performed	NULL
in	NULL
which	NULL
the	NULL
cDNAs	NULL
from	NULL
the	NULL
five	NULL
clones	NULL
were	NULL
transfected	NULL
into	NULL
strain	NULL
Â¥190	NULL
.	NULL

The	NULL
resultant	NULL
cells	NULL
were	NULL
mated	NULL
with	NULL
strain	NULL
Y187	NULL
transfected	NULL
with	NULL
seven	NULL
different	NULL
cDNAs	NULL
(	NULL
Fig	NULL
.	NULL

la	NULL
)	NULL
fused	NULL
with	NULL
the	NULL
GAL4	NULL
DNA	NULL
binding	NULL
domain	NULL
in	NULL
the	NULL
pASl	NULL
vector	NULL
,	NULL
Only	NULL
the	NULL
cells	NULL
expressing	NULL
the	NULL
p38	NULL
TY	NULL
mutant	NULL
and	NULL
the	NULL
five	NULL
test	NULL
clones	NULL
displayed	NULL
positive	NULL
galactosidase	NULL
activity	NULL
.	NULL

Sequencing	NULL
showed	NULL
that	NULL
each	NULL
clone	NULL
encoded	NULL
different	NULL
regions	NULL
of	NULL
the	NULL
same	NULL
protein	NULL
,	NULL
namely	NULL
,	NULL
myocyte	NULL
enhancer	NULL
factor	NULL
2C	NULL
(	NULL
MEF2C	NULL
)	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
belonging	NULL
to	NULL
the	NULL
MADS	NULL
superfamily	NULL
``	NULL
.	NULL

MEFZC	NULL
has	NULL
three	NULL
alternatively	NULL
spliced	NULL
exons	NULL
of	NULL
which	NULL
the	NULL
first	NULL
was	NULL
found	NULL
in	NULL
all	NULL
our	NULL
clones	NULL
while	NULL
alternatively	NULL
spliced	NULL
exons	NULL
two	NULL
or	NULL
three	NULL
were	NULL
absent	NULL
in	NULL
other	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

1b	NULL
)	NULL
.	NULL

The	NULL
MEF2C	NULL
used	NULL
for	NULL
subsequent	NULL
experiments	NULL
lacks	NULL
alternatively	NULL
spliced	NULL
exon	NULL
three	NULL
.	NULL

There	NULL
are	NULL
four	NULL
members	NULL
of	NULL
MEF2	NULL
gene	NULL
family	NULL
,	NULL
MEF2A-D	NULL
``	NULL
,	NULL
but	NULL
the	NULL
interaction	NULL
with	NULL
p38	NULL
seems	NULL
to	NULL
be	NULL
selective	NULL
for	NULL
MEF2C	NULL
,	NULL
as	NULL
no	NULL
other	NULL
members	NULL
of	NULL
this	NULL
family	NULL
have	NULL
been	NULL
isolated	NULL
by	NULL
two-hybrid	NULL
screening	NULL
even	NULL
though	NULL
the	NULL
cDNAs	NULL
encoding	NULL
these	NULL
other	NULL
proteins	NULL
are	NULL
in	NULL
the	NULL
brain	NULL
library	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
show	NULL
that	NULL
wtp38	NULL
and	NULL
MEF2C	NULL
interact	NULL
,	NULL
glutathione-agarose	NULL
,	NULL
with	NULL
or	NULL
without	NULL
bound	NULL
recombinant	NULL
GST-wtp38	NULL
,	NULL
was	NULL
incubated	NULL
with	NULL
varying	NULL
amounts	NULL
of	NULL
recombinant	NULL
MEF2C	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
ATP	NULL
.	NULL

Immunoblotting	NULL
revealed	NULL
saturable	NULL
binding	NULL
of	NULL
MEF2C	NULL
to	NULL
GST-wtp38-agarose	NULL
but	NULL
not	NULL
to	NULL
GST-agarose	NULL
(	NULL
Fig	NULL
.	NULL

lc	NULL
,	NULL
bottom	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
MEF2C	NULL
to	NULL
p38	NULL
was	NULL
not	NULL
detected	NULL
when	NULL
a	NULL
large	NULL
excess	NULL
of	NULL
cold	NULL
ATP	NULL
was	NULL
included	NULL
(	NULL
Fig	NULL
.	NULL

1Â¢	NULL
,	NULL
bottom	NULL
,	NULL
last	NULL
lane	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
MEF2C	NULL
was	NULL
detected	NULL
by	NULL
the	NULL
inclusion	NULL
of	NULL
P-ATP	NULL
in	NULL
the	NULL
incubation	NULL
mixtures	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
these	NULL
data	NULL
show	NULL
that	NULL
MEF2C	NULL
and	NULL
wtp38	NULL
interact	NULL
,	NULL
and	NULL
that	NULL
the	NULL
stability	NULL
of	NULL
this	NULL
interaction	NULL
is	NULL
reduced	NULL
after	NULL
phosphorylation	NULL
of	NULL
MEFC	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
other	NULL
MAPKs	NULL
can	NULL
phosphorylate	NULL
MEF2C	NULL
we	NULL
compared	NULL
the	NULL
activity	NULL
of	NULL
recombinant	NULL
p38	NULL
and	NULL
two	NULL
other	NULL
MAP	NULL
kinase	NULL
family	NULL
members	NULL
,	NULL
ERK2	NULL
and	NULL
JNK1	NULL
,	NULL
towards	NULL
MEF2C	NULL
(	NULL
Fig	NULL
.	NULL

1d	NULL
)	NULL
.	NULL

a	NULL
-	NULL
as	NULL
?	NULL

s	NULL
b	NULL
sor	NULL
g	NULL
g	NULL
r	NULL
sve	NULL
M	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
|	NULL
r	NULL
r	NULL
-	NULL
Jms	NULL
MEF2C	NULL
RN	NULL
wt	NULL
p38	NULL
mos	NULL
mer	NULL
~-F	NULL
Â®	NULL
Peck	NULL
p38	NULL
TY	NULL
mut	NULL
m	NULL
e	NULL
tne	NULL
manz	NULL
#	NULL
2	NULL
gates	NULL
rere	NULL
eres	NULL
SNF1	NULL
com	NULL
>	NULL
___	NULL
am	NULL
HPT	NULL
am	NULL
___	NULL
_	NULL
c	NULL
d	NULL
m	NULL
4	NULL
&	NULL
GST-wt	NULL
p38-Agarose	NULL
8	NULL
x	NULL
Â£	NULL
GST-Agarose	NULL
a	NULL
w	NULL
S	NULL
MEF2C	NULL
(	NULL
g	NULL
)	NULL
!	NULL

0	NULL
01	NULL
02	NULL
os	NULL
a	NULL
Cold	NULL
ATP	NULL
see	NULL
MEF2C	NULL
GST-wt	NULL
p38	NULL
#	NULL
Â»	NULL
coun	NULL
com	NULL
cm	NULL
cme	NULL
cs	NULL
lits	NULL
-a	NULL
c-Jun	NULL
His-MEF2C	NULL
#	NULL
|	NULL
lf	NULL
MEP	NULL
Figure	NULL
1	NULL
The	NULL
MAP	NULL
kinase	NULL
p38	NULL
interacts	NULL
with	NULL
MEF2C	NULL
.	NULL

a	NULL
,	NULL
Clones	NULL
isolated	NULL
from	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
screen	NULL
interact	NULL
selectively	NULL
with	NULL
the	NULL
p38	NULL
TY	NULL
mutant	NULL
.	NULL

Positive	NULL
interactions	NULL
are	NULL
indicated	NULL
by	NULL
B-gal	NULL
reporter	NULL
activity	NULL
of	NULL
lifted	NULL
yeast	NULL
clonies	NULL
,	NULL
shown	NULL
as	NULL
dark	NULL
spots	NULL
.	NULL

b	NULL
,	NULL
The	NULL
five	NULL
isolated	NULL
clones	NULL
all	NULL
encode	NULL
MEF2C	NULL
;	NULL
schematic	NULL
diagrams	NULL
of	NULL
the	NULL
sequence	NULL
of	NULL
each	NULL
clone	NULL
are	NULL
shown	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
full-length	NULL
MEF2C	NULL
cDNA	NULL
.	NULL

The	NULL
boundaries	NULL
of	NULL
the	NULL
MADS	NULL
and	NULL
MEF2	NULL
boxes	NULL
are	NULL
indicated	NULL
:	NULL
alternatively	NULL
spliced	NULL
regions	NULL
are	NULL
shown	NULL
by	NULL
open	NULL
boxes	NULL
.	NULL

e	NULL
,	NULL
MEFZC	NULL
binds	NULL
to	NULL
wtp38	NULL
in	NULL
vitro	NULL
.	NULL

d	NULL
,	NULL
MEFZC	NULL
is	NULL
phosphorylated	NULL
selectively	NULL
by	NULL
p38	NULL
but	NULL
not	NULL
by	NULL
other	NULL
MAP	NULL
kinases	NULL
.	NULL

NATURE	NULL
!	NULL

VOL	NULL
386120	NULL
MARCH	NULL
1997	NULL
MEF2C	NULL
is	NULL
indeed	NULL
a	NULL
preferred	NULL
substrate	NULL
of	NULL
p38	NULL
;	NULL
not	NULL
unexpectedly	NULL
,	NULL
other	NULL
substrate	NULL
preferences	NULL
were	NULL
observed	NULL
for	NULL
ERK2	NULL
or	NULL
JNK1	NULL
(	NULL
Fig	NULL
.	NULL

1d	NULL
)	NULL
.	NULL

Quantification	NULL
of	NULL
MEF2C	NULL
phosphorylation	NULL
showed	NULL
that	NULL
p38	NULL
is	NULL
16-fold	NULL
more	NULL
active	NULL
than	NULL
ERK2	NULL
and	NULL
100-fold	NULL
more	NULL
active	NULL
than	NULL
JNK1	NULL
;	NULL
the	NULL
relative	NULL
enzyme	NULL
activities	NULL
were	NULL
normalized	NULL
using	NULL
MBP	NULL
.	NULL

MEF2C	NULL
transcripts	NULL
have	NULL
previously	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
enriched	NULL
in	NULL
skeletal	NULL
muscle	NULL
,	NULL
spleen	NULL
and	NULL
brain	NULL
'	NULL
``	NULL
~	NULL
``	NULL
.	NULL

By	NULL
using	NULL
RNase	NULL
protection	NULL
assays	NULL
with	NULL
a	NULL
MEF2C	NULL
probe	NULL
corresponding	NULL
to	NULL
bases	NULL
404-695	NULL
,	NULL
we	NULL
|	NULL
observed	NULL
mRNA	NULL
expression	NULL
in	NULL
primary	NULL
monocytes	NULL
,	NULL
in	NULL
monocyte-	NULL
like	NULL
cell	NULL
lines	NULL
THP-1	NULL
and	NULL
U937	NULL
,	NULL
and	NULL
in	NULL
the	NULL
B-cell	NULL
line	NULL
Akata	NULL
,	NULL
but	NULL
not	NULL
in	NULL
HepG2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
.	NULL

MEF2C	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
bind	NULL
to	NULL
AT-rich	NULL
DNA	NULL
sequences	NULL
present	NULL
in	NULL
promoters	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
genes	NULL
``	NULL
``	NULL
.	NULL

To	NULL
evaluate	NULL
whether	NULL
activation	NULL
of	NULL
monocytic	NULL
cells	NULL
with	NULL
LPS	NULL
influences	NULL
proteins	NULL
in	NULL
nuclear	NULL
extracts	NULL
that	NULL
bind	NULL
to	NULL
a	NULL
MEF2	NULL
site	NULL
,	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
performed	NULL
using	NULL
oligonu-	NULL
letters	NULL
to	NULL
nature	NULL
cleotides	NULL
encoding	NULL
a	NULL
MEF2	NULL
binding	NULL
site	NULL
'	NULL
``	NULL
.	NULL

Treating	NULL
RAW	NULL
264.7	NULL
cells	NULL
with	NULL
LPS	NULL
resulted	NULL
in	NULL
a	NULL
time-dependent	NULL
increase	NULL
in	NULL
MEF2-site	NULL
binding	NULL
activity	NULL
,	NULL
reaching	NULL
a	NULL
maximum	NULL
1h	NULL
after	NULL
stimulation	NULL
with	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
.	NULL

This	NULL
binding	NULL
activity	NULL
can	NULL
be	NULL
competed	NULL
with	NULL
the	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
MEF2	NULL
site	NULL
but	NULL
not	NULL
a	NULL
mutated	NULL
MEF2	NULL
site	NULL
.	NULL

To	NULL
investigate	NULL
further	NULL
how	NULL
p38	NULL
regulates	NULL
MEF2C	NULL
we	NULL
used	NULL
a	NULL
modified	NULL
form	NULL
of	NULL
MEFZC	NULL
in	NULL
which	NULL
the	NULL
MADS	NULL
and	NULL
MEF2	NULL
domains	NULL
were	NULL
deleted	NULL
,	NULL
with	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
protein	NULL
containing	NULL
a	NULL
transactivation	NULL
domain	NULL
``	NULL
fused	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
yeast	NULL
transcription	NULL
factor	NULL
GAL4	NULL
.	NULL

This	NULL
fusion	NULL
protein	NULL
will	NULL
bind	NULL
to	NULL
GAL4	NULL
DNA-binding	NULL
sites	NULL
and	NULL
can	NULL
be	NULL
used	NULL
to	NULL
study	NULL
interactions	NULL
between	NULL
p38	NULL
and	NULL
MEF2C	NULL
without	NULL
complications	NULL
from	NULL
the	NULL
effects	NULL
of	NULL
other	NULL
endogenous	NULL
proteins	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
GAL4-MEF2C	NULL
protein	NULL
,	NULL
RAW	NULL
264.7	NULL
or	NULL
THP-1	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
a	NULL
a	NULL
5	NULL
8	NULL
$	NULL
i	NULL
$	NULL
q	NULL
2	NULL
I	NULL
4	NULL
%	NULL
&	NULL
ss	NULL
l	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
0	NULL
0.5	NULL
1	NULL
2	NULL
5	NULL
fsg'wnm	NULL
*	NULL
<	NULL
mme	NULL
|	NULL
Â«	NULL
4	NULL
MEFZC	NULL
u	NULL
Â®	NULL
E	NULL
B	NULL
w	NULL
Figure	NULL
2	NULL
Investigation	NULL
of	NULL
MEFZC	NULL
in	NULL
myeloid	NULL
lineage	NULL
cells	NULL
.	NULL

a	NULL
,	NULL
RNase	NULL
protection	NULL
|	NULL
experiments	NULL
show	NULL
that	NULL
MEF2C	NULL
mRNA	NULL
is	NULL
present	NULL
in	NULL
myeloid	NULL
lineage	NULL
cells	NULL
and	NULL
cell	NULL
i	NULL
lines	NULL
.	NULL

b	NULL
,	NULL
LPS	NULL
induces	NULL
MEFZ-site	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
the	NULL
murine	NULL
|-	NULL
capon	NULL
|	NULL
â€œ	NULL
I	NULL
cell	NULL
line	NULL
RAW	NULL
264.7.	NULL
c	NULL
,	NULL
LPS	NULL
treatment	NULL
or	NULL
expressions	NULL
of	NULL
MKK6b	NULL
(	NULL
E	NULL
)	NULL
increases	NULL
C	NULL
]	NULL
)	NULL
k.	NULL
-	NULL
.	NULL

--	NULL
MEF2C-dependent	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
;	NULL
this	NULL
increase	NULL
is	NULL
â‚¬	NULL
046	NULL
,	NULL
(	NULL
s	NULL
d	NULL
inhibited	NULL
by	NULL
the	NULL
p38-specific	NULL
inhibitor	NULL
FHPI	NULL
,	NULL
which	NULL
is	NULL
identical	NULL
to	NULL
SB	NULL
202190	NULL
(	NULL
ref	NULL
.	NULL

7	NULL
}	NULL
.	NULL

|	NULL
I	NULL
|	NULL
Â§	NULL
*	NULL
d	NULL
,	NULL
Expression	NULL
of	NULL
dominantnegative	NULL
p38	NULL
(	NULL
p38	NULL
(	NULL
M	NULL
)	NULL
)	NULL
inhibits	NULL
LPS-induced	NULL
,	NULL
MEF2C-8	NULL
}	NULL
#	NULL
â€˜	NULL
l	NULL
#	NULL
LPS	NULL
+/+	NULL
dependent	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
RAW	NULL
cells	NULL
.	NULL

e	NULL
,	NULL
p38	NULL
is	NULL
the	NULL
main	NULL
MEF2C	NULL
8	NULL
*j	NULL
J	NULL
Depletion	NULL
|_	NULL
|	NULL
,	NULL
,	NULL
(	NULL
y	NULL
,	NULL
_	NULL
kinase	NULL
in	NULL
LPS	NULL
(	NULL
10	NULL
ng	NULL
ml-	NULL
'	NULL
,	NULL
SO	NULL
min	NULL
}	NULL
-stimulated	NULL
RAW	NULL
cells	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
an	NULL
in-*	NULL
g	NULL
1	NULL
1	NULL
â€˜	NULL
a	NULL
wih	NULL
R	NULL
gel	NULL
!	NULL

kinase	NULL
assay	NULL
.	NULL

Depletion	NULL
of	NULL
p38	NULL
in	NULL
the	NULL
cell	NULL
lysate	NULL
was	NULL
achieved	NULL
by	NULL
using	NULL
anti-30	NULL
A	NULL
A	NULL
â€œ	NULL
|	NULL
Â§	NULL
r	NULL
}	NULL
||	NULL
|	NULL
|	NULL
-	NULL
p38	NULL
polyclonal	NULL
antibody	NULL
.	NULL

-	NULL
|	NULL
m	NULL
I	NULL
|	NULL
Â¢	NULL
|	NULL
~	NULL
ol	NULL
â€œ	NULL
1,11	NULL
â€œ	NULL
(	NULL
ELL-ll	NULL
.	NULL

â€œ	NULL
nanfi	NULL
__|	NULL
Â§	NULL
14	NULL
1	NULL
GALAMEFRC	NULL
+	NULL
+	NULL
4	NULL
6a	NULL
%	NULL
.	NULL

GAL	NULL
i	NULL
%	NULL
+8	NULL
la	NULL
o	NULL
4	NULL
1	NULL
1	NULL
1_1_I	NULL
â€˜	NULL
.	NULL

F	NULL
R	NULL
+	NULL
azn	NULL
pos	NULL
Â»	NULL
LPS	NULL
.	NULL

+	NULL
-	NULL
+	NULL
+	NULL
p38	NULL
(	NULL
4	NULL
)	NULL
mmsmsis	NULL
PhPi-	NULL
)	NULL
rom	NULL
LPs	NULL
-	NULL
+	NULL
Â¥	NULL
i	NULL
k	NULL
+	NULL
a	NULL
b	NULL
Peptide	NULL
1	NULL
:	NULL
INNSQSAQSLATÂ®Â®PVYSVATÂ®PTLP	NULL
c	NULL
GOGMGGYPSAISTTYGTEYSLSSADLSSLSGFN	NULL
TASALHLGSVTGWOQQHLHNMPPSALSQLGOR	NULL
Peptide	NULL
2	NULL
:	NULL
YDGSDR	NULL
P-Ser	NULL
P-Thr	NULL
>	NULL
WT	NULL
gar	NULL
-	NULL
pass	NULL
Â£	NULL
--	NULL
;	NULL
-	NULL
v	NULL
3	NULL
â€œ	NULL
l	NULL
3	NULL
LPs	NULL
+	NULL
s	NULL
.-	NULL
}	NULL
P-Tyr	NULL
\	NULL
F	NULL
~	NULL
U-	NULL
@	NULL
-	NULL
a	NULL
0	NULL
E	NULL
+	NULL
o	NULL
pH1.9	NULL
Electrophoresis	NULL
pH	NULL
8.9	NULL
d	NULL
e	NULL
10	NULL
--	NULL
WT	NULL
Untreated	NULL
wtTirs	NULL
gar	NULL
r	NULL
Â¥	NULL
LJ	NULL
a	NULL
8	NULL
4	NULL
â‚¬	NULL
youse	NULL
7	NULL
a	NULL
.	NULL

Â®	NULL
%	NULL
+	NULL
Â®	NULL
Â£	NULL
S*	NULL
``	NULL
Lps	NULL
Tem-	NULL
ips	NULL
2	NULL
H	NULL
gor	NULL
:	NULL
Â¥	NULL
IC	NULL
&	NULL
Â«	NULL
a	NULL
1	NULL
N	NULL
o	NULL
GAL4-MEF2C	NULL
(	NULL
WT	NULL
)	NULL
bad	NULL
Electrophoresis	NULL
pH	NULL
8.9	NULL
Figure	NULL
3	NULL
MEFZC	NULL
transactivation	NULL
activity	NULL
increased	NULL
by	NULL
LPS	NULL
is	NULL
mediated	NULL
by	NULL
p38	NULL
through	NULL
phosphorylation	NULL
of	NULL
MEF2C	NULL
on	NULL
Thr	NULL
293	NULL
(	NULL
T	NULL
``	NULL
*Â°	NULL
)	NULL
,	NULL
Thr	NULL
300	NULL
(	NULL
TÂ°	NULL
)	NULL
and	NULL
Ser	NULL
387	NULL
(	NULL
S	NULL
``	NULL
)	NULL
.	NULL

a	NULL
,	NULL
Phosphoamino-acid	NULL
analysis	NULL
of	NULL
MEF2C	NULL
phosphorylated	NULL
by	NULL
p38	NULL
in	NULL
vitro	NULL
.	NULL

b	NULL
,	NULL
Phosphopeptide	NULL
mapping	NULL
of	NULL
MEFZC	NULL
phosphorylated	NULL
by	NULL
p38	NULL
in	NULL
vitro	NULL
.	NULL

a	NULL
,	NULL
LPS	NULL
induces	NULL
phosphorylation	NULL
of	NULL
GAL4-MEF2C	NULL
fusion	NULL
protein	NULL
and	NULL
its	NULL
mutants	NULL
from	NULL
NATUREIVOL	NULL
386120	NULL
MARCH	NULL
1997	NULL
GALAMEF2C	NULL
(	NULL
SÂ®	NULL
``	NULL
)	NULL
GALA	NULL
GAL4MEFC	NULL
(	NULL
TÂ®	NULL
.	NULL

Â»	NULL
*	NULL
MKK6b	NULL
(	NULL
E	NULL
)	NULL
LPS	NULL
permanently	NULL
transfected	NULL
RAW	NULL
264.7	NULL
cells	NULL
metabolically	NULL
labelled	NULL
with	NULL
P.	NULL
d	NULL
,	NULL
in	NULL
vivo	NULL
phosphopeptide	NULL
mapping	NULL
of	NULL
GAL4-MEFZC	NULL
and	NULL
its	NULL
mutants	NULL
.	NULL

e	NULL
,	NULL
The	NULL
influence	NULL
of	NULL
the	NULL
mutation	NULL
of	NULL
phosphorylation	NULL
sites	NULL
of	NULL
MEF2C	NULL
on	NULL
MEFZC-dependent	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

Mutations	NULL
at	NULL
the	NULL
phosphorylation	NULL
sites	NULL
of	NULL
MEFZC	NULL
reduced	NULL
MKKSBb	NULL
(	NULL
E	NULL
}	NULL
-	NULL
or	NULL
LPS-enhanced	NULL
MEF2C-dependent	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

,	NULL
297	NULL
letters	NULL
to	NULL
nature	NULL
luciferase	NULL
reporter	NULL
gene	NULL
containing	NULL
five	NULL
copies	NULL
of	NULL
a	NULL
GAL4-binding	NULL
site	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
promoter	NULL
(	NULL
5XGAL4-luc	NULL
)	NULL
and	NULL
a	NULL
GAL4-MEF2C	NULL
expression	NULL
plasmid	NULL
.	NULL

LPS	NULL
treatment	NULL
increased	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
GAL4-MEF2C-dependent	NULL
reporter	NULL
gene	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

2Â¢	NULL
,	NULL
d	NULL
)	NULL
.	NULL

Co-transfection	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
p38	NULL
activator	NULL
,	NULL
MKK6b	NULL
``	NULL
,	NULL
also	NULL
increased	NULL
luciferase	NULL
expression	NULL
in	NULL
THP-1	NULL
(	NULL
Fig	NULL
.	NULL

2Â¢	NULL
)	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

MKK6b	NULL
{	NULL
(	NULL
E	NULL
)	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
stronger	NULL
activator	NULL
than	NULL
LPS	NULL
,	NULL
perhaps	NULL
because	NULL
LPS	NULL
activates	NULL
p38	NULL
only	NULL
transiently	NULL
,	NULL
whereas	NULL
activation	NULL
by	NULL
MKK6b	NULL
{	NULL
(	NULL
E	NULL
)	NULL
is	NULL
continuous	NULL
.	NULL

This	NULL
idea	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
stimulation	NULL
with	NULL
LPS	NULL
of	NULL
cells	NULL
already	NULL
expressing	NULL
MKK6b	NULL
{	NULL
(	NULL
E	NULL
)	NULL
,	NULL
GAL4-MEF2C	NULL
and	NULL
a	NULL
reporter	NULL
gene	NULL
failed	NULL
to	NULL
increase	NULL
luciferase	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
the	NULL
p38	NULL
inhibitor	NULL
FHPT	NULL
``	NULL
Â°	NULL
reduced	NULL
reporter	NULL
gene	NULL
expression	NULL
induced	NULL
by	NULL
LPS	NULL
or	NULL
MKK6b	NULL
(	NULL
E	NULL
)	NULL
in	NULL
THP-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2Â¢	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
dominant-negative	NULL
p38	NULL
with	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
ATP	NULL
binding	NULL
site	NULL
(	NULL
Lys	NULL
53	NULL
to	NULL
Met	NULL
)	NULL
also	NULL
inhibited	NULL
LPS-induced	NULL
enhancement	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

2d	NULL
)	NULL
;	NULL
dominant-negative	NULL
p38	NULL
also	NULL
blocked	NULL
MKK6b	NULL
(	NULL
EB	NULL
)	NULL
-induced	NULL
luciferase	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

An	NULL
in-gel	NULL
kinase	NULL
assay	NULL
``	NULL
using	NULL
recombinant	NULL
MEF2C	NULL
as	NULL
substrate	NULL
showed	NULL
that	NULL
p38	NULL
is	NULL
the	NULL
major	NULL
kinase	NULL
in	NULL
lysates	NULL
from	NULL
LPS-treated	NULL
RAW	NULL
264.7	NULL
cells	NULL
that	NULL
is	NULL
responsible	NULL
for	NULL
phosphorylation	NULL
of	NULL
MEF2C	NULL
(	NULL
Fig	NULL
.	NULL

2e	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
recombinant	NULL
MEF2C	NULL
with	NULL
p38	NULL
in	NULL
vitro	NULL
followed	NULL
by	NULL
phosphoamino-acid	NULL
analysis	NULL
indicated	NULL
that	NULL
p38	NULL
can	NULL
phosphorylate	NULL
both	NULL
serine	NULL
and	NULL
threonine	NULL
residues	NULL
of	NULL
MEF2C	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
were	NULL
performed	NULL
using	NULL
phosphopeptide	NULL
mapping	NULL
strategies	NULL
to	NULL
identify	NULL
the	NULL
exact	NULL
sequences	NULL
phosphorylated	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
.	NULL

By	NULL
analysing	NULL
the	NULL
electrical	NULL
charge	NULL
and	NULL
the	NULL
mass	NULL
of	NULL
all	NULL
the	NULL
tryptic	NULL
peptides	NULL
of	NULL
MEF2C	NULL
'	NULL
``	NULL
``	NULL
,	NULL
we	NULL
have	NULL
predicted	NULL
the	NULL
sequences	NULL
of	NULL
the	NULL
two	NULL
phosphopeptides	NULL
of	NULL
MEF2C	NULL
in	NULL
Fig	NULL
.	NULL

3b	NULL
that	NULL
seem	NULL
to	NULL
be	NULL
targeted	NULL
by	NULL
p38	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
peptide	NULL
1	NULL
had	NULL
a	NULL
higher	NULL
level	NULL
of	NULL
phosphorylation	NULL
than	NULL
peptide	NULL
2	NULL
.	NULL

Because	NULL
MAP	NULL
kinases	NULL
favour	NULL
sites	NULL
containing	NULL
proline	NULL
,	NULL
we	NULL
believe	NULL
that	NULL
Thr	NULL
293	NULL
and	NULL
Thr	NULL
300	NULL
in	NULL
peptide	NULL
1	NULL
and	NULL
Ser	NULL
387	NULL
in	NULL
peptide	NULL
2	NULL
are	NULL
phosphorylated	NULL
by	NULL
p38	NULL
(	NULL
Fig	NULL
.	NULL

3b	NULL
)	NULL
.	NULL

These	NULL
two	NULL
threonines	NULL
are	NULL
the	NULL
logical	NULL
candidates	NULL
for	NULL
phosphorylation	NULL
sites	NULL
because	NULL
p38	NULL
phosphorylates	NULL
MEF2C	NULL
on	NULL
both	NULL
threonine	NULL
and	NULL
serine	NULL
residues	NULL
(	NULL
Fig	NULL
.	NULL

3a	NULL
)	NULL
,	NULL
and	NULL
Thr	NULL
293	NULL
and	NULL
Thr	NULL
300	NULL
are	NULL
the	NULL
only	NULL
threonine	NULL
residues	NULL
followed	NULL
by	NULL
a	NULL
proline	NULL
in	NULL
MEF2C	NULL
.	NULL

Thr	NULL
293	NULL
and	NULL
Thr	NULL
300	NULL
are	NULL
located	NULL
in	NULL
a	NULL
previously	NULL
identified	NULL
transactivation	NULL
domain	NULL
of	NULL
MEF2C	NULL
``	NULL
.	NULL

To	NULL
establish	NULL
whether	NULL
these	NULL
sites	NULL
are	NULL
phosphorylated	NULL
after	NULL
treatment	NULL
with	NULL
LPS	NULL
,	NULL
and	NULL
to	NULL
investigate	NULL
whether	NULL
their	NULL
phosphorylation	NULL
results	NULL
in	NULL
regulation	NULL
of	NULL
MEF2C	NULL
transactivation	NULL
activity	NULL
,	NULL
we	NULL
created	NULL
a	NULL
mutant	NULL
of	NULL
GAL4-MEF2C	NULL
in	NULL
which	NULL
Thr	NULL
293	NULL
and	NULL
Thr	NULL
300	NULL
,	NULL
Ser	NULL
387	NULL
,	NULL
were	NULL
mutated	NULL
to	NULL
alanine	NULL
.	NULL

By	NULL
using	NULL
constructs	NULL
encoding	NULL
wild-type	NULL
GAL4-MEF2C	NULL
and	NULL
the	NULL
two	NULL
mutants	NULL
we	NULL
trans-	NULL
a	NULL
b	NULL
c	NULL
20	NULL
8	NULL
&	NULL
i	NULL
f	NULL
16	NULL
&	NULL
&	NULL
5	NULL
x	NULL
+	NULL
â‚¬	NULL
â‚¬	NULL
FA	NULL
|	NULL
$	NULL
e	NULL
Â®	NULL
42	NULL
g	NULL
5	NULL
'	NULL
Â©	NULL
a	NULL
$	NULL
a	NULL
Â©	NULL
5	NULL
|	NULL
l	NULL
Â©	NULL
3	NULL
|	NULL
=	NULL
C	NULL
v	NULL
o	NULL
2	NULL
'	NULL
t	NULL
+	NULL
Â¢-Jun	NULL
2	NULL
a	NULL
â‚¬	NULL
c	NULL
8	NULL
4	NULL
&	NULL
All	NULL
&	NULL
|	NULL
a	NULL
LQ	NULL
L4	NULL
o	NULL
pJiuc	NULL
+o+	NULL
-	NULL
-	NULL
-	NULL
pdluc	NULL
top	NULL
k	NULL
40+	NULL
pJSXluc	NULL
-	NULL
-	NULL
LPS	NULL
bok	NULL
#	NULL
04	NULL
[	NULL
MKKGD	NULL
(	NULL
E	NULL
)	NULL
+	NULL
A	NULL
MEF2C	NULL
:	NULL
wT	NULL
Witt	NULL
ll	NULL
allt	NULL
l	NULL
|	NULL
<	NULL
-	NULL
GAPDH	NULL
LPS	NULL
nthe	NULL
me	NULL
fl	NULL
n	NULL
or	NULL
mutants	NULL
__	NULL
__	NULL
--	NULL
~~	NULL
]	NULL
u	NULL
Figure	NULL
4	NULL
Phosphorylation	NULL
of	NULL
MEFZC	NULL
increases	NULL
transcription	NULL
activity	NULL
of	NULL
c-Jun	NULL
promoter	NULL
.	NULL

a	NULL
,	NULL
LPS	NULL
stimulation	NULL
or	NULL
coexpression	NULL
of	NULL
MKK6b	NULL
{	NULL
E	NULL
)	NULL
enhances	NULL
c-Jun	NULL
promoter-driven	NULL
reporter	NULL
gene	NULL
expression	NULL
;	NULL
mutation	NULL
of	NULL
MEFZ-site	NULL
reduced	NULL
the	NULL
increase	NULL
.	NULL

b	NULL
,	NULL
The	NULL
influence	NULL
of	NULL
overexpression	NULL
of	NULL
MEF2C	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
and	NULL
its	NULL
mutants	NULL
Thr	NULL
293	NULL
,	NULL
300	NULL
(	NULL
grey	NULL
bars	NULL
)	NULL
and	NULL
Ser	NULL
387	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
on	NULL
LPS-induced	NULL
c-Jun	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

Â¢	NULL
,	NULL
Inhibition	NULL
of	NULL
p38	NULL
activity	NULL
by	NULL
FHP	NULL
!	NULL

(	NULL
3	NULL
M	NULL
)	NULL
inhibited	NULL
LPS	NULL
(	NULL
10	NULL
ng	NULL
ml~	NULL
'	NULL
,	NULL
40	NULL
min	NULL
}	NULL
-induced	NULL
c-Jun	NULL
transcription	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
northern	NULL
blotting	NULL
analysis	NULL
.	NULL

298	NULL
fected	NULL
RAW	NULL
264.7	NULL
cells	NULL
and	NULL
selected	NULL
stable	NULL
transfectants	NULL
.	NULL

Phosphorylation	NULL
of	NULL
the	NULL
GAL4-MEF2C	NULL
fusion	NULL
proteins	NULL
was	NULL
detected	NULL
using	NULL
in	NULL
vivo	NULL
labelling	NULL
with	NULL
*P-orthophosphate	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
LPS	NULL
,	NULL
which	NULL
induced	NULL
phosphorylation	NULL
of	NULL
GAL4-MEF2C	NULL
fusion	NULL
proteins	NULL
;	NULL
the	NULL
induced	NULL
phosphorylation	NULL
was	NULL
reduced	NULL
when	NULL
Thr	NULL
293	NULL
,	NULL
Thr	NULL
300	NULL
or	NULL
Ser	NULL
387	NULL
was	NULL
mutated	NULL
to	NULL
alanine	NULL
(	NULL
Fig	NULL
.	NULL

3Â¢	NULL
)	NULL
.	NULL

Peptide	NULL
mapping	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3d	NULL
)	NULL
revealed	NULL
that	NULL
the	NULL
inducible	NULL
phosphorylation	NULL
occurred	NULL
on	NULL
two	NULL
peptides	NULL
identical	NULL
to	NULL
those	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3b	NULL
.	NULL

The	NULL
Ser	NULL
387	NULL
mutation	NULL
led	NULL
to	NULL
loss	NULL
of	NULL
inducible	NULL
phosphorylation	NULL
of	NULL
peptide	NULL
2	NULL
,	NULL
whereas	NULL
inducible	NULL
phosphorylation	NULL
of	NULL
peptide	NULL
1	NULL
was	NULL
prevented	NULL
by	NULL
using	NULL
the	NULL
GAL4-MEFZC	NULL
with	NULL
mutations	NULL
of	NULL
Thr	NULL
293	NULL
and	NULL
Thr	NULL
300	NULL
(	NULL
Fig	NULL
.	NULL

3d	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
p38	NULL
is	NULL
important	NULL
in	NULL
the	NULL
LPS-induced	NULL
phosphorylation	NULL
of	NULL
MEF2C	NULL
,	NULL
as	NULL
the	NULL
phosphorylation	NULL
sites	NULL
identified	NULL
in	NULL
these	NULL
whole-cell	NULL
studies	NULL
are	NULL
the	NULL
same	NULL
as	NULL
those	NULL
observed	NULL
from	NULL
in	NULL
vitro	NULL
phosphorylation	NULL
studies	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
phosphorylation	NULL
of	NULL
MEF2C	NULL
controls	NULL
its	NULL
transactivation	NULL
activity	NULL
,	NULL
a	NULL
reporter	NULL
gene	NULL
assay	NULL
was	NULL
performed	NULL
.	NULL

The	NULL
Thr	NULL
293	NULL
and	NULL
Thr	NULL
300	NULL
and	NULL
Ser	NULL
387	NULL
mutants	NULL
are	NULL
not	NULL
activated	NULL
by	NULL
the	NULL
coexpression	NULL
of	NULL
MKK6b	NULL
{	NULL
(	NULL
E	NULL
)	NULL
or	NULL
the	NULL
addition	NULL
of	NULL
LPS	NULL
,	NULL
but	NULL
a	NULL
control	NULL
Ser	NULL
240	NULL
mutant	NULL
behaved	NULL
identically	NULL
to	NULL
native	NULL
MEF2C	NULL
(	NULL
Fig	NULL
.	NULL

3â‚¬	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
promoters	NULL
of	NULL
many	NULL
LPS-inducible	NULL
genes	NULL
revealed	NULL
a	NULL
MEF2C	NULL
site	NULL
in	NULL
the	NULL
c-Jun	NULL
promoter	NULL
that	NULL
was	NULL
previously	NULL
suggested	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
serum-induced	NULL
c-Jun	NULL
expression	NULL
'	NULL
``	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
this	NULL
MEF2	NULL
site	NULL
and	NULL
p38	NULL
activation	NULL
in	NULL
LPS	NULL
induced	NULL
c-Jun	NULL
gene	NULL
expression	NULL
we	NULL
used	NULL
the	NULL
constructs	NULL
pJluc	NULL
,	NULL
with	NULL
the	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
c-Jun	NULL
promoter	NULL
(	NULL
-	NULL
225	NULL
to	NULL
+150	NULL
base	NULL
pairs	NULL
)	NULL
,	NULL
and	NULL
pJSXluc	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
mutated	NULL
MEF2	NULL
site	NULL
``	NULL
.	NULL

LPS	NULL
stimulation	NULL
or	NULL
MKK6b	NULL
{	NULL
E	NULL
)	NULL
expression	NULL
increased	NULL
c-Jun	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
MEF2	NULL
site	NULL
in	NULL
the	NULL
c-Jun	NULL
promoter	NULL
dramatically	NULL
reduced	NULL
the	NULL
induction	NULL
of	NULL
reporter-gene	NULL
expression	NULL
by	NULL
either	NULL
LPS	NULL
stimulation	NULL
or	NULL
by	NULL
expression	NULL
of	NULL
MKK6b	NULL
(	NULL
E	NULL
)	NULL
,	NULL
Thus	NULL
the	NULL
MEF2	NULL
site	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
LPS-induced	NULL
c-Jun	NULL
expression	NULL
.	NULL

We	NULL
next	NULL
overexpressed	NULL
MEF2C	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Overexpression	NULL
of	NULL
MEF2C	NULL
inhibited	NULL
LPS-induced	NULL
c-Jun	NULL
reporter	NULL
expression	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
MEF2C	NULL
homo-dimers	NULL
exert	NULL
a	NULL
negative	NULL
regulatory	NULL
effect	NULL
as	NULL
a	NULL
result	NULL
of	NULL
competition	NULL
with	NULL
MEF2C	NULL
heterodimer	NULL
(	NULL
s	NULL
)	NULL
that	NULL
are	NULL
likely	NULL
to	NULL
enhance	NULL
gene	NULL
transcription	NULL
.	NULL

This	NULL
interpretation	NULL
was	NULL
further	NULL
supported	NULL
by	NULL
results	NULL
showing	NULL
that	NULL
expression	NULL
of	NULL
MEFZC	NULL
with	NULL
mutations	NULL
of	NULL
either	NULL
Thr	NULL
293	NULL
and	NULL
Thr	NULL
300	NULL
or	NULL
at	NULL
Ser	NULL
387	NULL
had	NULL
a	NULL
much	NULL
stronger	NULL
inhibitory	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
because	NULL
their	NULL
expression	NULL
not	NULL
only	NULL
increases	NULL
the	NULL
homodimer	NULL
formation	NULL
but	NULL
also	NULL
results	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
defective	NULL
hetero-dimers	NULL
.	NULL

Inhibition	NULL
of	NULL
p38	NULL
activity	NULL
by	NULL
FHPI	NULL
also	NULL
markedly	NULL
inhibited	NULL
LPS-induced	NULL
c-Jun	NULL
mRNA	NULL
expression	NULL
(	NULL
~65	NULL
%	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4Â¢c	NULL
)	NULL
.	NULL

These	NULL
data	NULL
support	NULL
the	NULL
idea	NULL
that	NULL
MEFZC	NULL
participates	NULL
in	NULL
LPS-induced	NULL
c-Jun	NULL
expression	NULL
through	NULL
p38-induced	NULL
phosphorylation	NULL
.	NULL

We	NULL
know	NULL
of	NULL
no	NULL
data	NULL
that	NULL
directly	NULL
link	NULL
MEF2C	NULL
activation	NULL
to	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
that	NULL
for	NULL
tumour	NULL
necrosis	NULL
factor	NULL
.	NULL

However	NULL
,	NULL
p38-enhanced	NULL
c-Jun	NULL
expression	NULL
might	NULL
contribute	NULL
to	NULL
LPS-induced	NULL
changes	NULL
in	NULL
AP-1	NULL
or	NULL
the	NULL
AP-1/CRE-like	NULL
element	NULL
binding	NULL
activity	NULL
in	NULL
monocytic	NULL
cells	NULL
``	NULL
``	NULL
,	NULL
as	NULL
the	NULL
modulation	NULL
of	NULL
these	NULL
DNA-binding	NULL
activities	NULL
by	NULL
LPS	NULL
requires	NULL
de	NULL
novo	NULL
protein	NULL
synthesis*	NULL
``	NULL
.	NULL

Cytokine	NULL
genes	NULL
typically	NULL
have	NULL
AP-1/CRE-like	NULL
ele-ments	NULL
.	NULL

Thus	NULL
,	NULL
for	NULL
infection	NULL
with	NULL
multiple	NULL
exposures	NULL
to	NULL
microbial	NULL
pathogens	NULL
such	NULL
as	NULL
LPS	NULL
,	NULL
MEF2C	NULL
activation	NULL
might	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
controlling	NULL
the	NULL
balance	NULL
of	NULL
cytokine	NULL
production	NULL
through	NULL
its	NULL
effects	NULL
on	NULL
c-Jun	NULL
expression	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
that	NULL
stimulation	NULL
with	NULL
LPS	NULL
leads	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
JNK	NULL
and	NULL
the	NULL
subsequent	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
``	NULL
.	NULL

Thus	NULL
LPS	NULL
activation	NULL
results	NULL
in	NULL
consumption	NULL
of	NULL
c-Jun	NULL
protein	NULL
,	NULL
and	NULL
p38-induced	NULL
MEF2C	NULL
activation	NULL
results	NULL
in	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
c-Jun	NULL
gene	NULL
,	NULL
which	NULL
itself	NULL
would	NULL
result	NULL
in	NULL
the	NULL
replenishment	NULL
of	NULL
c-Jun	NULL
protein	NULL
.	NULL

Because	NULL
p38	NULL
and	NULL
JNK	NULL
are	NULL
also	NULL
quite	NULL
often	NULL
activated	NULL
together	NULL
by	NULL
important	NULL
phlogistic	NULL
stimuli	NULL
such	NULL
as	NULL
interleukin-1	NULL
or	NULL
tumour	NULL
necrosis	NULL
factor	NULL
,	NULL
these	NULL
two	NULL
MAP	NULL
kinase	NULL
pathways	NULL
may	NULL
also	NULL
be	NULL
linked	NULL
during	NULL
many	NULL
conditions	NULL
in	NULL
which	NULL
inflammatory	NULL
responses	NULL
are	NULL
upregulated	NULL
.	NULL

CU	NULL
NATURE	NULL
!	NULL

VOL	NULL
386120	NULL
MARCH	NULL
1997	NULL
Methods	NULL
Yeast	NULL
two-hybrid	NULL
system	NULL
.	NULL

The	NULL
two-hybrid	NULL
screen	NULL
,	NULL
mating	NULL
experiments	NULL
,	NULL
and	NULL
X-gal	NULL
colony	NULL
filter	NULL
assay	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
``	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
of	NULL
p38	NULL
and	NULL
MEF2C	NULL
.	NULL

Glutathione-agarose	NULL
beads	NULL
bound	NULL
with	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
of	NULL
wtp38	NULL
(	NULL
GST-wtp38	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
different	NULL
amounts	NULL
of	NULL
MEF2C	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
250	NULL
mM	NULL
NaC	NULL
,	NULL
25mM	NULL
imidazole	NULL
and	NULL
0.05	NULL
%	NULL
Triton-X-100	NULL
)	NULL
containing	NULL
2	NULL
%	NULL
BSA	NULL
with	NULL
or	NULL
without	NULL
cold	NULL
ATP	NULL
(	NULL
20	NULL
uM	NULL
)	NULL
for	NULL
3	NULL
h	NULL
after	NULL
blocking	NULL
the	NULL
nonspecific	NULL
binding	NULL
with	NULL
2	NULL
%	NULL
BSA	NULL
in	NULL
buffer	NULL
A	NULL
for	NULL
3	NULL
h.	NULL
After	NULL
the	NULL
beads	NULL
were	NULL
washed	NULL
6	NULL
times	NULL
with	NULL
buffer	NULL
A	NULL
,	NULL
they	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
followed	NULL
by	NULL
transfer	NULL
to	NULL
nictocellulose	NULL
;	NULL
His-MEF2C	NULL
was	NULL
detected	NULL
using	NULL
Ni-NTA	NULL
conjugated	NULL
with	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
Qiagen	NULL
)	NULL
,	NULL
and	NULL
GST-p38	NULL
was	NULL
detected	NULL
with	NULL
rabbit	NULL
anti-p38	NULL
antibody	NULL
together	NULL
with	NULL
peroxidase	NULL
coupled	NULL
to	NULL
sheep	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
Cappel	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
kinase	NULL
assays	NULL
.	NULL

Equal	NULL
amounts	NULL
(	NULL
2	NULL
pg	NULL
)	NULL
of	NULL
His-MEF2C	NULL
,	NULL
GST-c-Jun	NULL
(	NULL
residues	NULL
1-93	NULL
)	NULL
``	NULL
or	NULL
MBP	NULL
(	NULL
Sigma	NULL
)	NULL
were	NULL
used	NULL
as	NULL
substrates	NULL
.	NULL

His-tagged	NULL
wtp38	NULL
(	NULL
ref	NULL
.	NULL

4	NULL
)	NULL
,	NULL
His-tagged	NULL
ERK2	NULL
(	NULL
ref	NULL
,	NULL
25	NULL
)	NULL
or	NULL
flag-tagged	NULL
JNK1	NULL
(	NULL
ref	NULL
.	NULL

3	NULL
)	NULL
were	NULL
used	NULL
as	NULL
kinases	NULL
.	NULL

The	NULL
kinase	NULL
reaction	NULL
and	NULL
quantification	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
.	NULL

EMSA	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
RAW	NULL
264.7	NULL
cells	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
(	NULL
10	NULL
ng	NULL
ml~	NULL
'	NULL
)	NULL
for	NULL
different	NULL
times	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
double-stranded	NULL
,	NULL
4p	NULL
.	NULL

labelled	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
MEF2	NULL
binding	NULL
site	NULL
as	NULL
a	NULL
probe	NULL
``	NULL
.	NULL

An	NULL
unlabelled	NULL
MEF2	NULL
oligonucleotide	NULL
probe	NULL
and	NULL
an	NULL
oligonucleotide	NULL
with	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
MEF	NULL
]	NULL
site	NULL
(	NULL
MEF2mut	NULL
)	NULL
``	NULL
'	NULL
were	NULL
used	NULL
as	NULL
competitors	NULL
to	NULL
determine	NULL
the	NULL
binding	NULL
specificity	NULL
.	NULL

Reporter	NULL
gene	NULL
assays	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
DEAE-Dextran	NULL
``	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
with	NULL
calcium	NULL
phosphateÂ®	NULL
``	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
B-galactosidase	NULL
expression	NULL
vector	NULL
pCMV-B	NULL
,	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
pGSE1-blue	NULL
,	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
encoding	NULL
a	NULL
GAL4-MEF2C	NULL
fusion	NULL
protein	NULL
or	NULL
GAL4	NULL
{	NULL
(	NULL
I-147	NULL
)	NULL
or	NULL
GAL4-MEF2C	NULL
mutants	NULL
,	NULL
and	NULL
with	NULL
the	NULL
expression	NULL
vector	NULL
encoding	NULL
a	NULL
constitutively	NULL
active	NULL
form	NULL
of	NULL
MKK6b	NULL
(	NULL
E	NULL
)	NULL
or	NULL
with	NULL
empty	NULL
vector	NULL
pcDNA3	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
the	NULL
cells	NULL
were	NULL
also	NULL
transfected	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
DNA	NULL
(	NULL
0	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
or	NULL
16g	NULL
)	NULL
from	NULL
an	NULL
expression	NULL
plasmid	NULL
for	NULL
p38	NULL
(	NULL
M	NULL
)	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
for	NULL
each	NULL
transfection	NULL
was	NULL
kept	NULL
constant	NULL
using	NULL
pcDNA3	NULL
.	NULL

In	NULL
studies	NULL
using	NULL
FHPI	NULL
,	NULL
the	NULL
inhibitor	NULL
was	NULL
added	NULL
(	NULL
3	NULL
uM	NULL
)	NULL
36h	NULL
after	NULL
transfection	NULL
for	NULL
1	NULL
h	NULL
;	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
for	NULL
8h	NULL
.	NULL

LPS	NULL
(	NULL
5	NULL
pug	NULL
ml~	NULL
'	NULL
and	NULL
10	NULL
ng	NULL
ml~	NULL
'	NULL
)	NULL
was	NULL
used	NULL
to	NULL
stimulate	NULL
THP-1	NULL
and	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
relative	NULL
luciferase	NULL
activities	NULL
presented	NULL
were	NULL
normalized	NULL
by	NULL
dividing	NULL
the	NULL
luciferase	NULL
activity	NULL
by	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Phosphoamino-acid	NULL
analysis	NULL
and	NULL
phosphopeptide	NULL
mapping	NULL
.	NULL

These	NULL
methods	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
``	NULL
.	NULL

GAL4-MEF2C	NULL
fusion	NULL
protein	NULL
and	NULL
mutants	NULL
from	NULL
[	NULL
*Plorthophosphate-labelled	NULL
permanently	NULL
transfected	NULL
RAW	NULL
264.7	NULL
cells	NULL
(	NULL
1	NULL
mCiml~	NULL
'	NULL
,	NULL
2h	NULL
)	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
(	NULL
10	NULL
ngml~	NULL
'	NULL
,	NULL
2h	NULL
)	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-GAL4	NULL
DNA-binding	NULL
domain	NULL
monoclonal	NULL
antibody	NULL
RK5C1	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
.	NULL

Received	NULL
18	NULL
November	NULL
1996	NULL
;	NULL
accepted	NULL
21	NULL
January	NULL
1997	NULL
.	NULL

1	NULL
.	NULL

Morrison	NULL
,	NULL
D.	NULL
C.	NULL
et	NULL
al	NULL
.	NULL

Bacterial	NULL
endotoxins	NULL
and	NULL
pathogenesis	NULL
of	NULL
Gram-negative	NULL
infections	NULL
:	NULL
current	NULL
status	NULL
and	NULL
future	NULL
direction	NULL
.	NULL

J.	NULL
Endotoxin	NULL
Res	NULL
.	NULL

1	NULL
,	NULL
71-83	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

2	NULL
.	NULL

Blumer	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

&	NULL
Johnson	NULL
,	NULL
G.	NULL
L.	NULL
Diversity	NULL
in	NULL
function	NULL
and	NULL
regulation	NULL
of	NULL
MAP	NULL
kinase	NULL
pathways	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

19	NULL
,	NULL
236-240	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

3	NULL
.	NULL

Derijard	NULL
,	NULL
B.	NULL
et	NULL
al	NULL
.	NULL

JNK1	NULL
:	NULL
A	NULL
protein	NULL
kinase	NULL
stimulated	NULL
by	NULL
UV	NULL
light	NULL
and	NULL
Ha-Ras	NULL
that	NULL
binds	NULL
and	NULL
phosphorylates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Cell	NULL
76	NULL
,	NULL
1025-1037	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

4	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Lee	NULL
,	NULL
J.-D.	NULL
,	NULL
Bibbs	NULL
,	NULL
L.	NULL
&	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

A	NULL
MAP	NULL
kinase	NULL
targeted	NULL
by	NULL
endotoxin	NULL
and	NULL
hyperosmolarity	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
265	NULL
,	NULL
808-811	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

5	NULL
.	NULL

Zhou	NULL
,	NULL
G.	NULL
,	NULL
Bao	NULL
,	NULL
Z.	NULL
Q	NULL
.	NULL

&	NULL
Dixon	NULL
,	NULL
J.	NULL
E.	NULL
Components	NULL
of	NULL
a	NULL
new	NULL
human	NULL
protein	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chen	NULL
,	NULL
270	NULL
,	NULL
12665-12669	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

6	NULL
.	NULL

Lee	NULL
,	NULL
J.-D.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

&	NULL
Han	NULL
,	NULL
J	NULL
.	NULL

Primary	NULL
structure	NULL
of	NULL
BMKi	NULL
:	NULL
A	NULL
new	NULL
mammalian	NULL
MAP	NULL
kinase	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

213	NULL
,	NULL
715-724	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

7	NULL
.	NULL

Leo	NULL
,	NULL
J.	NULL
C.	NULL
et	NULL
al	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
protein	NULL
kinase	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
inflammatory	NULL
cytokine	NULL
biosynthesis	NULL
.	NULL

Nature	NULL
372	NULL
,	NULL
739-746	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

8	NULL
.	NULL

Raingeaud	NULL
,	NULL
J.	NULL
ef	NULL
al	NULL
.	NULL

Pro-inflammatory	NULL
cytokines	NULL
and	NULL
environmental	NULL
stress	NULL
cause	NULL
p38	NULL
MAP	NULL
kinase	NULL
activation	NULL
by	NULL
dual	NULL
phosphorylation	NULL
on	NULL
Lyrosine	NULL
and	NULL
threonine	NULL
,	NULL
.	NULL

Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
7420-7426	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

9	NULL
.	NULL

Beyaett	NULL
,	NULL
R.	NULL
et	NULL
al	NULL
.	NULL

The	NULL
p38/RK	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathway	NULL
regulates	NULL
interleukin-6	NULL
synthesis	NULL
in	NULL
response	NULL
to	NULL
tumour	NULL
necrosis	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
1914-1923	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

10	NULL
.	NULL

Martin	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Schwarz	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

&	NULL
Olson	NULL
,	NULL
E.	NULL
N.	NULL
Myocyte	NULL
enhancer	NULL
factor	NULL
(	NULL
MEF	NULL
)	NULL
2C	NULL
:	NULL
A	NULL
tissue-restricted	NULL
member	NULL
of	NULL
the	NULL
MEF-2	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
5282-5286	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

McDermott	NULL
,	NULL
J.	NULL
C.	NULL
ef	NULL
al	NULL
.	NULL

hMED2C	NULL
gene	NULL
encodes	NULL
skeletal	NULL
muscle-	NULL
and	NULL
brain-specific	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
2564-2577	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

12	NULL
.	NULL

Leifer	NULL
,	NULL
D.	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
11546-1550	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

13	NULL
.	NULL

Durfee	NULL
,	NULL
T.	NULL
et	NULL
al	NULL
.	NULL

The	NULL
retinoblastoma	NULL
protein	NULL
associates	NULL
with	NULL
the	NULL
protein	NULL
phosphatase	NULL
type	NULL
1	NULL
catalytic	NULL
subunit	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
555-569	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

14	NULL
.	NULL

Martin	NULL
,	NULL
J.	NULL
F.	NULL
ef	NULL
al	NULL
.	NULL

A	NULL
Mef2	NULL
gene	NULL
that	NULL
generates	NULL
a	NULL
muscle-specific	NULL
isoform	NULL
via	NULL
alternative	NULL
mRNA	NULL
splicing	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1647-1656	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

.	NULL

Molkentin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Black	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
Martin	NULL
,	NULL
J.	NULL
F.	NULL
&	NULL
Olson	NULL
,	NULL
E.	NULL
N.	NULL
Mutational	NULL
analysis	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
,	NULL
dimerization	NULL
,	NULL
and	NULL
transcriptional	NULL
activation	NULL
domains	NULL
of	NULL
MEFZC	NULL
.	NULL

Mol	NULL
,	NULL
Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
2627-2636	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

t	NULL
NATURE	NULL
]	NULL
VOL	NULL
386/20	NULL
MARCH	NULL
1997	NULL
letters	NULL
to	NULL
nature	NULL
16	NULL
.	NULL

Jiang	NULL
,	NULL
Y.	NULL
et	NULL
al	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
a	NULL
new	NULL
mitogen-activate	NULL
protein	NULL
kinase	NULL
(	NULL
p38B	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
17920-17926	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

17	NULL
.	NULL

Wang	NULL
,	NULL
H.-C.	NULL
&	NULL
Erikson	NULL
,	NULL
R.	NULL
L.	NULL
Activation	NULL
of	NULL
protein	NULL
serine/threonine	NULL
kinases	NULL
p42	NULL
,	NULL
p63	NULL
,	NULL
and	NULL
p87	NULL
in	NULL
Rous	NULL
sarcoma	NULL
virus-transformed	NULL
cells	NULL
:	NULL
Signal	NULL
transduction/transformation-dependent	NULL
MBP	NULL
kinases	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
3	NULL
,	NULL
1329-1337	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

18	NULL
.	NULL

Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
VanDerGree	NULL
,	NULL
P.	NULL
&	NULL
Hunter	NULL
,	NULL
T.	NULL
Phosphopeptide	NULL
mapping	NULL
and	NULL
phosphoamino	NULL
acid	NULL
analysis	NULL
by	NULL
two	NULL
dimensional	NULL
separation	NULL
on	NULL
thin-layer	NULL
cellulose	NULL
plates	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

201	NULL
,	NULL
110-148	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

19	NULL
.	NULL

Han	NULL
,	NULL
T.-H.	NULL
&	NULL
Prywes	NULL
,	NULL
R.	NULL
Regulatory	NULL
role	NULL
of	NULL
MEF2D	NULL
in	NULL
serum	NULL
induction	NULL
of	NULL
the	NULL
c-jun	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
,	NULL
Biol	NULL
,	NULL
15	NULL
,	NULL
2907-2915	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

20	NULL
.	NULL

Newell	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Deisseroth	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

&	NULL
Lopez-Berestein	NULL
,	NULL
G.	NULL
Interaction	NULL
of	NULL
nuclear	NULL
proteins	NULL
with	NULL
an	NULL
AP-1/	NULL
CRE-like	NULL
promoter	NULL
sequence	NULL
in	NULL
the	NULL
human	NULL
TNF-alpha	NULL
gene	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

56	NULL
,	NULL
27-35	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

21	NULL
.	NULL

Shin	NULL
,	NULL
H.	NULL
S.	NULL
et	NULL
al	NULL
.	NULL

Definition	NULL
of	NULL
a	NULL
lipapolysaccharide-responsive	NULL
element	NULL
in	NULL
the	NULL
5	NULL
``	NULL
-flanking	NULL
regions	NULL
of	NULL
MuRantes	NULL
and	NULL
crg-2	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

(	NULL
Author	NULL
:	NULL
Volume	NULL
?	NULL

Pages	NULL
?	NULL
)	NULL

22	NULL
.	NULL

Mackman	NULL
,	NULL
N.	NULL
,	NULL
Brand	NULL
,	NULL
K.	NULL
&	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
Lipopolysaccharide-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
tissue	NULL
factor	NULL
gene	NULL
in	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
requires	NULL
both	NULL
activator	NULL
protein	NULL
1	NULL
and	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
binding	NULL
sites	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174	NULL
,	NULL
1517-1526	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

.	NULL

Fujihara	NULL
,	NULL
M.	NULL
,	NULL
Muroi	NULL
,	NULL
M.	NULL
,	NULL
Murai	NULL
,	NULL
Y.	NULL
,	NULL
Ito	NULL
,	NULL
N.	NULL
&	NULL
Suzuki	NULL
,	NULL
T.	NULL
Mechanism	NULL
of	NULL
lipopolysaccharide-triggered	NULL
junB	NULL
activation	NULL
in	NULL
a	NULL
mouse	NULL
macrophage-like	NULL
cell	NULL
line	NULL
(	NULL
J774	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Che	NULL
.	NULL

268	NULL
,	NULL
14898-14905	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Hambleton	NULL
,	NULL
J.	NULL
,	NULL
Weinstein	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Lem	NULL
,	NULL
L.	NULL
&	NULL
DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
Activation	NULL
of	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
in	NULL
bacterial	NULL
lipupolysaccharide-stimulated	NULL
macrophages	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
2774-2778	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

25	NULL
.	NULL

Robbins	NULL
,	NULL
D.	NULL
J.	NULL
et	NULL
al	NULL
.	NULL

Regulation	NULL
and	NULL
properties	NULL
of	NULL
extracellular	NULL
signal-regulated	NULL
protein	NULL
kinases	NULL
1	NULL
and	NULL
2	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
5097-5106	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

.	NULL

Han	NULL
,	NULL
J.	NULL
ef	NULL
al	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
structure	NULL
and	NULL
function	NULL
of	NULL
a	NULL
novel	NULL
MAP	NULL
kinase	NULL
kinase	NULL
(	NULL
MKK6	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
2886-2891	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

27	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Brown	NULL
,	NULL
T	NULL
,	NULL
&	NULL
Beutler	NULL
,	NULL
B.	NULL
Endotoxin-responsive	NULL
sequences	NULL
control	NULL
cachectin/tumo	NULL
necrosis	NULL
factor	NULL
biosynthesis	NULL
at	NULL
the	NULL
translational	NULL
level	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
465-475	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

2	NULL
te	NULL
24.	NULL
os	NULL
2	NULL
5	NULL
Acknowledgements	NULL
,	NULL
We	NULL
thank	NULL
L.	NULL
Wu	NULL
for	NULL
the	NULL
help	NULL
with	NULL
two-hybrid	NULL
screening	NULL
;	NULL
R.	NULL
J.	NULL
Davis	NULL
for	NULL
JNK1	NULL
cDNA	NULL
;	NULL
M.	NULL
Karin	NULL
for	NULL
GST-c-Jun	NULL
(	NULL
1-93	NULL
)	NULL
expression	NULL
plasmid	NULL
;	NULL
R.	NULL
Prywes	NULL
for	NULL
pfluc	NULL
and	NULL
pJSXluc	NULL
reporter	NULL
constructs	NULL
;	NULL
and	NULL
B.	NULL
Chastain	NULL
for	NULL
secretarial	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
and	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
.	NULL

J.	NULL
Han	NULL
is	NULL
an	NULL
established	NULL
investigator	NULL
of	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
.	NULL

Correspondence	NULL
and	NULL
requests	NULL
for	NULL
materials	NULL
should	NULL
be	NULL
addressed	NULL
to	NULL
J.	NULL
H.	NULL
(	NULL
e-mail	NULL
:	NULL
jhan	NULL
@	NULL
scripps.edu	NULL
}	NULL
.	NULL

Direct	NULL
observation	NULL
of	NULL
the	NULL
rotation	NULL
of	NULL
F	NULL
,	NULL
-ATPase	NULL
Hiroyuki	NULL
Noji*	NULL
,	NULL
Ryohei	NULL
Yasuda	NULL
,	NULL
Masasuke	NULL
Yoshida*	NULL
&	NULL
Kazuhiko	NULL
Kinosita	NULL
Jri	NULL
*	NULL
Research	NULL
Laboratory	NULL
of	NULL
Resources	NULL
Utilization	NULL
,	NULL
Tokyo	NULL
Institute	NULL
of	NULL
Technology	NULL
,	NULL
Nagatsuta	NULL
4259	NULL
,	NULL
Midori-ku	NULL
,	NULL
Yokohama	NULL
226	NULL
,	NULL
Japan	NULL
t	NULL
Department	NULL
of	NULL
Physics	NULL
,	NULL
Faculty	NULL
of	NULL
Science	NULL
and	NULL
Technology	NULL
,	NULL
Keio	NULL
University	NULL
,	NULL
Cells	NULL
employ	NULL
a	NULL
variety	NULL
of	NULL
linear	NULL
motors	NULL
,	NULL
such	NULL
as	NULL
myosin	NULL
'	NULL
~	NULL
,	NULL
kinesin	NULL
'	NULL
and	NULL
RNA	NULL
polymerase	NULL
``	NULL
,	NULL
which	NULL
move	NULL
along	NULL
and	NULL
exert	NULL
force	NULL
on	NULL
a	NULL
filamentous	NULL
structure	NULL
.	NULL

But	NULL
only	NULL
one	NULL
rotary	NULL
motor	NULL
has	NULL
been	NULL
investigated	NULL
in	NULL
detail	NULL
,	NULL
the	NULL
bacterial	NULL
flagellumÂ®	NULL
(	NULL
a	NULL
complex	NULL
of	NULL
about	NULL
100	NULL
protein	NULL
molecules	NULL
'	NULL
)	NULL
,	NULL
We	NULL
now	NULL
show	NULL
that	NULL
a	NULL
single	NULL
molecule	NULL
of	NULL
F	NULL
;	NULL
-ATPase	NULL
acts	NULL
as	NULL
a	NULL
rotary	NULL
motor	NULL
,	NULL
the	NULL
smallest	NULL
known	NULL
,	NULL
by	NULL
direct	NULL
observation	NULL
of	NULL
its	NULL
motion	NULL
.	NULL

A	NULL
central	NULL
rotor	NULL
of	NULL
radius	NULL
~1	NULL
nm	NULL
,	NULL
formed	NULL
by	NULL
its	NULL
y-subunit	NULL
,	NULL
turns	NULL
in	NULL
a	NULL
stator	NULL
barrel	NULL
of	NULL
radius	NULL
~5nm	NULL
formed	NULL
by	NULL
three	NULL
Â«	NULL
-	NULL
and	NULL
three	NULL
B-subunits	NULL
'	NULL
.	NULL

F	NULL
;	NULL
-ATPase	NULL
,	NULL
together	NULL
with	NULL
the	NULL
membrane-embedded	NULL
proton-conduct-ing	NULL
unit	NULL
F	NULL
,	NULL
,	NULL
forms	NULL
the	NULL
H*-ATP	NULL
synthase	NULL
that	NULL
reversibly	NULL
couples	NULL
transmembrane	NULL
proton	NULL
flow	NULL
to	NULL
ATP	NULL
synthesis/hydrolysis	NULL
in	NULL
respiring	NULL
and	NULL
photosynthetic	NULL
cells	NULL
``	NULL
``	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
y-subunit	NULL
of	NULL
F	NULL
;	NULL
-ATPase	NULL
rotates	NULL
within	NULL
the	NULL
Â«	NULL
B-hexamer	NULL
``	NULL
,	NULL
a	NULL
conjecture	NULL
supported	NULL
by	NULL
structural	NULL
,	NULL
biochemical'*	NULL
``	NULL
and	NULL
spectroscopic	NULL
``	NULL
studies	NULL
.	NULL

We	NULL
attached	NULL
a	NULL
fluorescent	NULL
actin	NULL
filament	NULL
to	NULL
the	NULL
y-subunit	NULL
as	NULL
a	NULL
marker	NULL
,	NULL
which	NULL
enabled	NULL
us	NULL
to	NULL
observe	NULL
this	NULL
motion	NULL
directly	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
ATP	NULL
,	NULL
the	NULL
filament	NULL
rotated	NULL
for	NULL
more	NULL
than	NULL
100	NULL
revolutions	NULL
in	NULL
an	NULL
anticlockwise	NULL
direction	NULL
when	NULL
viewed	NULL
from	NULL
the	NULL
'membrane	NULL
'	NULL
side	NULL
.	NULL

The	NULL
rotary	NULL
torque	NULL
produced	NULL
reached	NULL
more	NULL
than	NULL
40	NULL
pN	NULL
nm	NULL
~	NULL
'	NULL
under	NULL
high	NULL
load	NULL
.	NULL

In	NULL
the	NULL
crystal	NULL
structure	NULL
of	NULL
mitochondrial	NULL
Fi-ATPaseÂ®	NULL
,	NULL
rigid	NULL
``	NULL
coiled-coil	NULL
Â«	NULL
-helices	NULL
of	NULL
the	NULL
y-subunit	NULL
penetrate	NULL
the	NULL
central	NULL
cavity	NULL
of	NULL
the	NULL
and	NULL
extend	NULL
into	NULL
the	NULL
stalk	NULL
region	NULL
that	NULL
links	NULL
F	NULL
;	NULL
-ATPase	NULL
to	NULL
the	NULL
F	NULL
,	NULL
portion	NULL
.	NULL

The	NULL
amino	NULL
terminus	NULL
of	NULL
the	NULL
B-subunits	NULL
is	NULL
on	NULL
the	NULL
side	NULL
opposite	NULL
the	NULL
stalk	NULL
region	NULL
of	NULL
the	NULL
y-subunit	NULL
.	NULL

To	NULL
fix	NULL
the	NULL
a	NULL
;	NULL
B3y	NULL
subcomplex	NULL
on	NULL
a	NULL
glass	NULL
plate	NULL
,	NULL
the	NULL
subcomplex	NULL
derived	NULL
from	NULL
a	NULL
thermophilic	NULL
bacterium	NULL
was	NULL
expressed	NULL
in	NULL
Escherichia	NULL
coli	NULL
,	NULL
with	NULL
ten	NULL
histidines	NULL
(	NULL
His	NULL
tag	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
each	NULL
B-subunit	NULL
.	NULL

The	NULL
299	NULL

